Annual CFO
-$184.74 M
NaN%
December 31, 2021
Summary
- As of February 10, 2025, ADGI annual cash flow from operations is -$184.74 million
Performance
ADGI Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$57.39 M
+$1.66 M+2.81%
June 30, 2022
Summary
- As of February 10, 2025, ADGI quarterly cash flow from operations is -$57.39 million, with the most recent change of +$1.66 million (+2.81%) on June 30, 2022.
- Over the past year, ADGI quarterly CFO has dropped by -$23.82 million (-70.96%).
Performance
ADGI Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$243.87 M
-$23.82 M-10.83%
June 30, 2022
Summary
- As of February 10, 2025, ADGI TTM cash flow from operations is -$243.87 million, with the most recent change of -$23.82 million (-10.83%) on June 30, 2022.
- Over the past year, ADGI TTM CFO has dropped by -$186.56 million (-325.51%).
Performance
ADGI TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADGI Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -71.0% | -325.5% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ADGI Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | +27.6% | +32.0% | at low |
| 5 y | 5-year | at high | at low | +141.7% | +27.6% | +927.2% | at low |
| alltime | all time | at high | at low | +141.7% | +27.6% | +927.2% | at low |
Adagio Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$57.39 M(-2.8%) | -$243.87 M(+10.8%) |
| Mar 2022 | - | -$59.05 M(-19.3%) | -$220.04 M(+19.1%) |
| Dec 2021 | -$184.74 M | -$73.21 M(+35.0%) | -$184.74 M(+65.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$54.21 M(+61.5%) | -$111.52 M(+94.6%) |
| Jun 2021 | - | -$33.57 M(+41.4%) | -$57.31 M(+141.4%) |
| Mar 2021 | - | -$23.74 M | -$23.74 M |
FAQ
- What is Adagio Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Adagio Therapeutics?
- What is Adagio Therapeutics quarterly CFO year-on-year change?
- What is Adagio Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Adagio Therapeutics?
- What is Adagio Therapeutics TTM CFO year-on-year change?
What is Adagio Therapeutics annual cash flow from operations?
The current annual CFO of ADGI is -$184.74 M
What is the all time high annual CFO for Adagio Therapeutics?
Adagio Therapeutics all-time high annual cash flow from operations is -$184.74 M
What is Adagio Therapeutics quarterly cash flow from operations?
The current quarterly CFO of ADGI is -$57.39 M
What is the all time high quarterly CFO for Adagio Therapeutics?
Adagio Therapeutics all-time high quarterly cash flow from operations is -$23.74 M
What is Adagio Therapeutics quarterly CFO year-on-year change?
Over the past year, ADGI quarterly cash flow from operations has changed by -$23.82 M (-70.96%)
What is Adagio Therapeutics TTM cash flow from operations?
The current TTM CFO of ADGI is -$243.87 M
What is the all time high TTM CFO for Adagio Therapeutics?
Adagio Therapeutics all-time high TTM cash flow from operations is -$23.74 M
What is Adagio Therapeutics TTM CFO year-on-year change?
Over the past year, ADGI TTM cash flow from operations has changed by -$186.56 M (-325.51%)